News

BioNTech Begins the COVID-19 Vaccine Trial Process

Written by Yourway | March 26, 2020

Though a formal COVID-19 trial is still weeks away, BioNTech is joining the pack of hopefuls with their mRNA vaccine, BNT162. BioNTech is currently developing the infrastructure needed to move forward with the trial. As a premium clinical supplies courier, Yourway has the tools (including all ancillary materials) and the expertise to help a company advance their trials globally.